• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORCYM S.R.L. OPTIFORM PROSTHETIC MITRAL HEART VALVE; MECHANICAL HEART VALVE PROSTHESIS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORCYM S.R.L. OPTIFORM PROSTHETIC MITRAL HEART VALVE; MECHANICAL HEART VALVE PROSTHESIS Back to Search Results
Model Number CPHV
Device Problem Difficult to Open or Close (2921)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/24/2022
Event Type  malfunction  
Manufacturer Narrative
A complete manufacturing and material records review for the device has been performed.The results confirmed that the device satisfied all material, visual and performance standards required at the time of manufacture and release.Since the device was discarded at the hospital due to blood contamination and was not returned to the manufacturer, no further investigation on the device is possible.Based on the manufacturer's experience, events of intra-operative leaflet dysfunction could occur due to interference of the patient's native mitral valve, when this is not fully removed, since the device was not returned to the manufacturer for further investigation, definite root cause of the reported event cannot be established.However, a review of the manufacturing and material records confirmed that the device satisfied all material, visual and performance standards required at the time of manufacture and release.Should further information be received in the future, the manufacturer will provide a follow up report.
 
Event Description
The manufacturer was informed of the dysfunction that noticed with the leaflets of the optiform valve.As reported, the mitral valve and calcified tissue were trimmed.After the implantation of the optiform valve size 29, it was noticed that the leaflets were stuck.The valve was removed.After the explant, the leaflets still were not moving and during checking the valve one of the leaflets broke and fell off.Another optiform valve (same model) was implanted in the patient as a replacement.As reported, the operation was successfully completed, the patient was not affected.
 
Event Description
On (b)(6) 2022, the following mitral valve replacement with optiform valve size 29 was performed.In this mvr, the mitral valve leaflets were removed, the tendinous cord of the anterior valve was fixed to the ascending of the posterior valve ring and all the subvalvular structures of the mitral valve were preserved.As reported, first, the anterior flap connecting the anterior and posterior papillary tendon into two sheets were trimmed (about 10mm × 50mm size).Then, the two pieces of flaky tissue were turned back and placed behind the posterior valve at the near anterior and posterior junction, and fix them behind the posterior leaflet with intermittent horizontal mattress suture with a gasket.Afterward, the f7-029 valve was implanted and the valve leaflets were opened in the fore-and-aft direction.After the implantation of the optiform valve size 29, it was noticed that the leaflets were stuck.The valve was removed.After the explant, the leaflets were still not moving and during checking the valve one of the leaflets broke and fell off.Another optiform valve (same model) was implanted in the patient as a replacement.As reported, the operation was successfully completed, and patient was not affected.
 
Manufacturer Narrative
Based on the manufacturer's experience, events of intra-operative leaflet dysfunction could occur due to interference of the patient's native mitral valve, when this is not fully removed ( as reported, the sub-valvular structures were preserved).Since the device was not returned to the manufacturer for further investigation, a definitive root cause of the reported event cannot be established.However, a review of the manufacturing and material records confirmed that the device satisfied all material, visual and performance standards required at the time of manufacture and release.Should further information be received in the future, the manufacturer will provide a follow up report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OPTIFORM PROSTHETIC MITRAL HEART VALVE
Type of Device
MECHANICAL HEART VALVE PROSTHESIS
Manufacturer (Section D)
CORCYM S.R.L.
strada crescentino
saluggia, vercelli
Manufacturer (Section G)
CORCYM S.R.L.
strada crescentino
saluggia, vercelli
Manufacturer Contact
francesca crovato
5005 north fraser way
burnaby, bc 
MDR Report Key14190545
MDR Text Key299060084
Report Number3005687633-2022-00118
Device Sequence Number1
Product Code LWQ
UDI-Device Identifier08022057012869
UDI-Public(01)08022057012869(240)F7-029(17)260516
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P900060/S019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/24/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberCPHV
Device Catalogue NumberF7-029
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 03/28/2022
Initial Date FDA Received04/22/2022
Supplement Dates Manufacturer Received04/29/2022
Supplement Dates FDA Received05/25/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/16/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-